Literature DB >> 26742649

Effects of lidocaine on torn rotator cuff tendons.

Hirokazu Honda1, Masafumi Gotoh2, Tomonoshin Kanazawa1,3, Hidehiro Nakamura1, Keisuke Ohta3, Kei-Ichiro Nakamura3, Naoto Shiba1.   

Abstract

We determined lidocaine's action on torn rotator cuff tendons in vitro and in vivo. For in vitro experiments, cell proliferation and viability assays were performed using tenocytes derived from human torn rotator cuff tendons. For in vivo experiments, acute rotator cuff tears were made on the supraspinatus tendons in the rats' bilateral shoulders; before closure, lidocaine was injected into the shoulder and saline into the contralateral shoulder (control). After sacrifice, the specimens underwent biomechanical testing or histological analysis at 24 h and at 2, 4, and 8 weeks after surgery. The extent of collagen organization and apoptosis were semi-quantitatively evaluated using collagen picrosirius red staining. Apoptosis was examined using TUNEL staining and electron microscopy. Cell proliferation decreased dose-dependently. After exposure to 0.1% lidocaine for 24 h, cell viability decreased. Two and 4 weeks after surgery, the ultimate load to failure decreased more in the lidocaine group than in the control group, with significantly reduced stiffness in the lidocaine group 2 weeks after surgery. Collagen organization significantly decreased in the lidocaine group by 4 weeks after surgery but returned to baseline at 8 weeks. TUNEL staining detected numerous apoptotic tenocytes at the torn tendon edge exposed to lidocaine 24 h after surgery; electron microscopy confirmed the condensed cell nuclei. These changes were not observed in controls. Lidocaine caused cytotoxicity to tenocytes under both conditions, decreased biomechanical properties, and induced apoptosis and delay of collagen organization in this model. Subacromial lidocaine injections in patients with rotator cuff tears should be performed carefully.
© 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1620-1627, 2016. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  lidocaine; rotator cuff; tendons; tenocytes

Mesh:

Substances:

Year:  2016        PMID: 26742649     DOI: 10.1002/jor.23153

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  5 in total

1.  Histomorphometric and ultrastructural analysis of the tendon-bone interface after rotator cuff repair in a rat model.

Authors:  Tomonoshin Kanazawa; Masafumi Gotoh; Keisuke Ohta; Hirokazu Honda; Hiroki Ohzono; Hisao Shimokobe; Naoto Shiba; Kei-Ichiro Nakamura
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

2.  Preoperative hyaluronic acid injection modulates postoperative functional outcome in patients undergoing arthroscopic rotator cuff repair.

Authors:  Yosuke Nakamura; Masafumi Gotoh; Yasuhiro Mitsui; Hidehiro Nakamura; Hiroki Ohzono; Takahiro Okawa; Naoto Shiba
Journal:  J Orthop Surg Res       Date:  2020-06-03       Impact factor: 2.359

3.  Neurotropin protects rotator cuff tendon cells from lidocaine-induced cell death.

Authors:  Ryunosuke Abe; Hiroki Ohzono; Masafumi Gotoh; Yosuke Nakamura; Hirokazu Honda; Hidehiro Nakamura; Shinichiro Kume; Takahiro Okawa; Naoto Shiba
Journal:  Clin Shoulder Elb       Date:  2021-12-01

4.  Lidocaine Inhibited Tendon Cell Proliferation and Extracellular Matrix Production by Down Regulation of Cyclin A, CDK2, Type I and Type III Collagen Expression.

Authors:  Yen-Chia Chen; Hsiang-Ning Chang; Jong-Hwei Su Pang; Li-Ping Lin; Jing-Min Chen; Tung-Yang Yu; Wen-Chung Tsai
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

5.  Protective effects of platelet-rich plasma against lidocaine cytotoxicity on canine articular chondrocytes.

Authors:  Erika Bianchini; Francesco Mancini; Antonio Di Meo; Anna Stabile; Sandra Buratta; Livia Moscati; Alessandra Pistilli; Claudia Floridi; Marco Pepe; Elisabetta Chiaradia
Journal:  Acta Vet Scand       Date:  2018-10-26       Impact factor: 1.695

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.